Evaluation of plasma Epstein-Barr virus DNA load to distinguish nasopharyngeal carcinoma patients from healthy high-risk populations in Southern China

Author： Ji Ming-Fang   Huang Qi-Hong   Yu Xia   Liu Zhiwei   Li Xinghua   Zhang Li-Fang   Wang Panpan   Xie Shang-Hang   Rao Hui-Lan   Fang Fang   Guo Xiang   Liu Qing   Hong Ming-Huang   Ye Weimin   Zeng Yi-Xin   Cao Su-Mei  

Publisher： Blackwell Publishing

E-ISSN： 1097-0142|120|9|1353-1360

ISSN： 0008-543X

Source： Cancer, Vol.120, Iss.9, 2014-05, pp. : 1353-1360

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Clinical utility of plasma Epstein-Barr virus DNA and ERCC1 single nucleotide polymorphism in nasopharyngeal carcinoma

By  

Cancer, Vol. 121, Iss. 16, 2015-08 ,pp. : 2720-2729

Blackwell Publishing

Access to resources Recommend Favorite

Epstein–Barr virus: the future for screening, treatment and monitoring of nasopharyngeal carcinoma

By Davis Joanne E   Smith Mark C   Coman William B   Moss Denis J  

Future Virology, Vol. 1, Iss. 2, 2006-03 ,pp. : 211-221

Future Medicine

Access to resources Recommend Favorite

The role of Epstein-Barr virus–encoded microRNA BART7 status of resection margins in the prediction of local recurrence after salvage nasopharyngectomy for recurrent nasopharyngeal carcinoma

By  

Cancer, Vol. 121, Iss. 14, 2015-07 ,pp. : 2358-2366

Blackwell Publishing

Access to resources Recommend Favorite

Lytic replication of Epstein–Barr virus

By Lu Chih-Chung   Chen Mei-Ru  

Future Virology, Vol. 1, Iss. 4, 2006-07 ,pp. : 435-446

Future Medicine

Access to resources Recommend Favorite

Epstein-Barr virus and multiple sclerosis: association or causation?

By Pakpoor Julia   Giovannoni Gavin   Ramagopalan Sreeram V  

Expert Review of Neurotherapeutics, Vol. 13, Iss. 3, 2013-03 ,pp. : 287-297

Informa Healthcare

Access to resources Recommend Favorite